NFKB1 and chronic myelogenous leukemia, BCR-ABL1 positive: The present study sheds light on a potential mechanism through which CML augments cancer stem cell properties and metastasis in osteosarcoma cells, achieved via RAGE-mediated activation of the NFκB signaling cascade.